| Structure |
Chemical Name |
CAS |
MF |
 |
DOPE-PEG-Glucose |
|
|
|
|
DOPE-PEG-Lactoferrin |
|
|
|
|
DOPE-PEG-FITC |
|
|
|
|
DOPE-PEG-CY5.5 |
|
|
|
|
MAL-PEOz-OH |
|
|
|
|
[CCP] Nunc 96-well clear bottom microplate, polystyrene/cover glass bottom, external dimensions 12886mm, surface Poly-D-Lysine, color, white, non-sterile, produced in clean environment | 96 well | Nunc |
|
|
|
|
Dopamine-PEG-MAL |
|
|
|
|
Polymethylpentene resin measuring cylinder 200ML[NIKKO]|200ML|AS-ONE/Azov |
|
|
|
|
[LPE] Amber wide mouth bottle, amber high density polyethylene, amber polypropylene screw cap, 1000ML capacity | 1000ML | NALGENE/Naijie |
|
|
|
|
[LPE] BOSTON ROUND narrow mouth bottle natural low density polyethylene natural color natural polypropylene cap 60ML non-sterile | 60ML | NALGENE / Naijie |
|
|
|
|
[LPE] MATRIX 0.5 ML 2D, Polypropylene, V-bottom screw cap cryotube with red cap, Bulk, Sterile, 48 tubes/pack, 10 packs/box | 0.5ML | THERMO SCIENTIFIC |
|
|
|
|
[LPE] Intravenous drip bottle, low-density polyethylene, 8ML capacity | 8ML | NALGENE/Naijie |
|
|
|
|
Polymethylpentene wide-mouth bottle (unsterilized) 500ML [NIKKO] | 500ML | AS-ONE / Azov |
|
|
|
|
L-6211 |
|
|
|
|
PVDF(HAJ603) |
|
|
|
|
[LPE] Narrow-mouth bottle with fluorinated high-density polyethylene and translucent fluorinated polypropylene cap 500ML Non-sterile | 500ML | NALGENE/Naijie |
|
|
|
|
5ΜM polyethylene (PET) filter membrane |
|
|
|
|
Rhodamine-PEG-DBCO |
|
|
|
|
CPSF73 Protein |
|
|
|
|
CSGLCAT Protein |
|
|
|
|
Dextranase Protein |
|
|
|
|
DNA polymerase subunit II Protein |
|
|
|
|
ELL Protein |
|
|
|
|
Glypican 5 Protein |
|
|
|
|
Anti-OGFOD2 antibody |
|
|
|
|
Anti-PARP antibody |
|
|
|
|
Cefixime polymer 2 |
|
|
|
|
Cartilage Oligomeric Matrix Protein Kit (COMP) R200800 |
|
|
|
|
Imidolastine dimer 3 |
|
|
|
|
Ceftazidime polymer |
|
|
|
|
COOH-PEG2000-Angiopep-2 |
|
|
|
|
Modified organic polysilazane RCF-601 has excellent hydrophobic properties |
|
|
|
|
PCL-PEG-SCM |
|
|
|
|
acid Palmitic-PEG- SH |
|
|
|
|
PLGA-PEG-COOH，PLGA-PEG-Acid |
|
|
|
|
EPO-PEG-DSPE |
|
|
|
|
Dopamine-PEG-N3 |
|
|
|
|
NHS-PEG-Gluconic acid |
|
|
|
|
PLA-PEG-AC |
|
|
|
|
Boc-NH-PEG-Ph-CHO |
|
|
|
|
NPC-PEG-CLS |
|
|
|
|
MAC-PEG-CLS |
|
|
|
|
NPC-PEG-ACA |
|
|
|
|
OH-PEG-Tocopherol |
|
|
|
|
Tocopherol-PEG-DBCO |
|
|
|
|
OPSS-PEG-Dopamine |
|
|
|
|
PCL-PEG-Alkyne |
|
|
|
|
PLGA-PEG-MAC |
|
|
|
|
8Arm PEG-PCL |
|
|
|
|
PCL-PEG-EPO |
|
|
|
|
monomethoxyl poly(ethylene glycol)-b-poly (L-lactide) |
|
|
|
|
DSPE-PEG-YSA(YSAYPDSVPMMS) |
|
|
|
|
mPEG-Amide-Butyraldehyde/Methoxy PEG-Amide-Butyraldehyde |
|
|
|
|
6-arm PEG-Thiol (Sulfhydryl) |
|
|
|
|
6-arm PEG-Succinic Acid |
|
|
|
|
4- arm PEG SuccinimidyI Carbonate |
|
|
|
|
PEG-di-Urethane Butyraldehyde |
|
|
|
|
PEG-di-Glutaric Acid |
|
|
|
|
17-(Bromoacetylamino-hexaethylene glycol-ethylcarbamoyl)heptanoic acid tert-butyl ester |
|
|
|
|
m-PEG6-glucosamine |
|
|
|
|
Pharmaceutical Grade Copolyvidone S680 |
|
|
|
|
DOTA-Pentaethylene glycol-C6-dibenzocyclooctyne |
|
|
|
|
Azido-PEG4-Amido-Lys(Fmoc)-Acid |
|
|
|
|
Tetrazine-PEG5-Tetrazine |
|
|
|
|
Alkyne-PEG2-SNAP |
|
|
|
|
DMG-PEG-N3 |
|
|
|
|
PEI-PLL |
|
|
|
|
PEI-PEG-FITC |
|
|
|
|
DSPE-Hyd-PEG-COOH |
|
|
|
|
(Bio-CS)BIOTIN-CS |
|
|
|
|
DSPE-TK-PEG-FA |
|
|
|
|
DSPE-TK-PEG-CHO |
|
|
|
|
Resorcinol oxidized trimer |
|
|
|
|
Cefcapene Pivoxil Dimer |
|
|
|
|
Methoxypolyethylene glycol ditetradecylamine MPEG-DTA-4 |
|
|
|
|
Polyethylene Glycol PEG-400DO |
|
|
|
|
DNA polymerase I (NG204-02) |
|
|
|
|
TAQ DNA polymerase (ET101-02-04 (including MG2+)) |
|
|
|
|
2000ml PFA Round-bottom flask |
|
|
|
|
HotStart B-Taq DNA polymerase |
|
|
|
|
Thalidomide-5-PEG4-COO(t-Bu) |
|
|
|
|
Thalidomide-5-amido-C1-PEG3-NHBoc |
|
|
|
|
Thalidomide-5-amido-C1-PEG2-COOH |
|
|
|
|
Lenalidomide-PEG3-C2-COO(t-Bu) |
|
|
|
|
2-Methylpropan-2-yl [(8-{[2-(2,6-Dioxohexahydropyridin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-4-yl]amino}-3,6-dioxaoct-1-yl)amino]methanoate |
|
|
|
|
3-[(8-{[2-(2,6-Dioxohexahydropyridin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-4-yl]amino}-3,6-dioxaoct-1-yl)oxy]propanoic Acid |
|
|
|
|
2-Methylpropan-2-yl ({2-[(2-{[2-(2,6-Dioxohexahydropyridin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-7-yl]oxy}ethyl)oxy]ethyl}amino)methanoate |
|
|
|
|
3-({2-[(2-{[2-(2,6-Dioxohexahydropyridin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-7-yl]oxy}ethyl)oxy]ethyl}oxy)propanoic Acid |
|
|
|
|
Lenalidomide-5'-PEG3-NH2 |
|
|
|
|
3-[(2-{[2-(2,6-Dioxohexahydropyridin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-6-yl]oxy}ethyl)oxy]propanoic Acid |
|
|
|
|
Lenalidomide-5'-PEG3-C2-NH2 |
|
|
|
|
2-Methylpropan-2-yl 3-[(8-{[2-(2,6-Dioxohexahydropyridin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-6-yl]amino}-3,6-dioxaoct-1-yl)oxy]propanoate |
|
|
 |
Lenalidomide-5'-CO-C1-PEG3-NH2 |
2940934-27-8 |
C21H28N4O7 |
|
|
Lenalidomide-5'-CO-C1-PEG2-COOH |
|
|
|
|
2-[(8-Amino-3,6-dioxaoct-1-yl)oxy]-N-[2-(2,6-dioxohexahydropyridin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-6-yl]acetamide |
|
|
|
|
Polyquaternary ammonium salt |
|
|
|
|
Soil Acid Xylanase (S-ACX) Activity Detection Kit |
|
|
|
|
Neutral Xylanase(NEX) Activity Assay Kit |
|
|
|
|
Soil Neutral Xylanase(S-NEX) Activity Assay Kit |
|
|
|
|
bioleaper? Human IL-17A/F Heterodimer ELISA kit |
|
|